The biological response to online hemodiafiltration

Contributions to Nephrology

Volumn 158, Issue , 2007, Pages 194-200

  Panichi, V ^a   Tetta, C ^b  

^a UNIVERSITY OF PISA   (Italy)

^b FRESENIUS MEDICAL CARE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODIALYSIS FLUID;

ARTICLE; CHRONIC KIDNEY FAILURE; HEMODIAFILTRATION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; METHODOLOGY; ONLINE SYSTEM; PATHOLOGY; PATHOPHYSIOLOGY; STANDARD; UREMIA;

HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; KIDNEY FAILURE, CHRONIC; ONLINE SYSTEMS; UREMIA;

EID: 34547982033     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000107250     Document Type: Article

References (31)

1. Vanholder R, De Smet R, Glorieux G, et al: Review on uremic toxins: classification, concentration, and. interindividual variability. Kidney Int. 2003;63:1934-1943.
2. Vanholder R, De Smet R, Lameire N: Protein-bound uremic solutes: the forgotten toxins. Kidney Int 2001;78(suppl):S266-S270.
3. Levey AS, Coresh J, Balk E, et al: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
4. Stenvinkel P, Pecoits-Filho R, Lindholm B: Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003;14:1927-1939.
5. Zoccali C, Tripepi G, Mallamaci F: Predictors of cardiovascular death, in. ESRD. Semin. Nephrol 2005;25:358-362.
6. Himmelfarb J, Ikizler TA, Stenvinkel P, Hakim RM: The elephant, in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538.
7. Morena M, Delbosc S, Dupuy AM, et al: Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005;9:37-46.
8. Brancaccio D, Tetta C, Gallieni M, Panichi V: Inflammation, CRP, calcium overload and a high calcium-phosphate product: a 'liaison dangereuse'. Nephrol Dial Transplant 2002;17:201-203.
9. Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, et al: Mortality and hospitalization in. haemodialysis patients in five European countries: results from the Dialysis Outcomes and. Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004;19:108-120.
10. Ganesh SK, Hulbert-Shearon T, Port FK, et al: Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003;14: 415-424.
11. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United. States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003;14:3270-3277.
12. Wolfe RA, Hulbert-Shearon TE, Ashby VB, et al: Improvements in dialysis patient mortality are associated, with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis 2005;45:127-135.
13. Goodkin DA, Mapes DL, Held. PJ: The Dialysis Outcomes and Practice Patterns Study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial 2001;14:157-159.
14. Yoshino M, Kuhlmann MK, Kotanko P, et al: International differences in dialysis mortality reflect background, general population atheroslerotic cardiovascular mortality. J Am Soc Nephrol 2006;17:3510-3519.
15. Ridker PM, Cushman M, Stampfer MJ, et al: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
16. Vasan RS, Sullivan LM, Roubenoff R, et al: Inflammatory markers and risk of heart failure in elderly subjects without, prior myocardial infarction: the Framingham Heart Study. Circulation 2003;107:1486-1491.
17. Liuzzo G, Biasucci LM, Gallimore JR, et al: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
18. Lagrand WK, Visser CA, Hermens WT, et al: C-reactive-protein as a cardiovascular risk: more than an epiphenomenon? Circulation 1999;100:96-102.
19. Carracedo J, Ramirez R, Madueno JA, et. al: Cell apoptosis and hemodialysis-induced inflammation. Kidney Int. Suppl 2002;80:89-93.
20. Lonnemann G: When good water goes bad: how it happens, clinical consequences and possible solutions. Blood Purif 2004;22:124-129.
21. Stenvinkel P, Ketteler M, Johnson RJ, et al: IL-10, IL-6, and TNF-α: central factors in the altered cytokine network, of uremia-The good, the bad, and the ugly. Kidney Int 2005;67:1216-1233.
22. Schwendler SB, Filep JG, Galle J, et al: C-reactive protein: a family of proteins to regulate cardio-vascular function. Am J Kidney Dis 2005;47:212-222.
23. Canaud B, Levesque R, Krieter D, et al: On line hemodiafiltration as routine treatment of end-stage renal failure: why pre- or mixed dilution mode is necessary in on line haemodiafiltration today? Blood. Purif 2004;22(suppl 2):40-48.
24. Passlick-Deetjen J, Pohlmeier R: On-line hemodiafiltration: gold standard or top therapy? In Ronco C, La Greca G (eds): Hemodialysis Technology. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 201-211.
25. Kerr PB, Argiles A, Flavier JL, Canaud B, Mion CM: Comparison, of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int. 1992;41:1035-1040.
26. Ward RA, Schmidt. B, Hullin J, Hillebrand. GF, Samtleben W: A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000;11:2344-2350.
27. Van Laecke S, De Wilde K, Vanholder R: On line hemodiafiltration. Artif Organs 2006;30: 579-585.
28. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, et al: Pre-dilution on-line haemodiafiltration vs low-flux haemodialysis: a randomized, prospective study. Nephrol Dial Transplant 2005;20:1155-1163.
29. Carracedo J, Merino A, Nogueras S, et al: CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study. JAm Soc Nephrol 2006;17:2315-2321. DOI: 10.1681/.
30. Ramirez R, Carracedo J, Merino A, et al: Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int 2007, E-pub ahead of print.
31. Locatelli F, Del Vecchio L, Pozzoni P, Andrulli S: Dialysis adequacy and response to erythopoiesis-stimulating agents: what is the evidence base? Semin Nephrol 2006;26;269-274.